Wakix

Wakix is used to treat narcolepsy in adults, adolescents and children from 6 years of age. Narcolepsy is a long-term sleep disorder which affects the brain’s ability to regulate the normal sleep-wake cycle. This leads to symptoms such as an irresistible urge to sleep, even at inappropriate times and places, and disturbed night-time sleep. Some patients also have episodes of severe muscle weakness (cataplexy) that can cause collapse. Wakix is used in patients with or without cataplexy. Narcolepsy is rare, and Wakix was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 10 July 2007. Further information on the orphan designation can be found here: [ema.europa.eu/medicines/human/orphan-designations/eu307459](http://www.). Wakix contains the active substance pitolisant.